PlainPharmaWatch

CMS Open Payments · Program Year 2024

Oxford Gene Technology Inc

Oxford Gene Technology Inc reported $2,323.62 in payments to 87 physicians and teaching hospitals across 87 transactions.

See the rankings → How this is sourced
$2.3K
Total payments
87
Transactions
87
Recipients
−$7.5K
General Payments vs PY2023

Oxford Gene Technology Inc reported $2,323.62 in payments to 87 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1786 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $26.71 per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Oxford Gene Technology Inc pairs modest payment volume with a broadly spread payment pattern across many recipients.

#1786
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
2
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Oxford Gene Technology Inc's CMS-reported General Payments decreased by $7.5K (−76.5%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: OXFORD GENE TECHNOLOGY INCPY2023: OXFORD GENE TECHNOLOGY INCPY2024: OXFORD GENE TECHNOLOGY INC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$9.9KPY2024$2.3K
PY2023
$9,867.06
PY2024
$2,323.62

How Oxford Gene Technology Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Oxford Gene Technology Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,324 7th percentile higher than 7% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). This entry sits in this band. $2,603–$8,084: 114 reporting companies (6%). Above this entry. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Oxford Gene Technology Inc

Rank #1786 of 1,925 companies in CMS Open Payments for 2024 belongs to Oxford Gene Technology Inc, which reported $2,323.62 across 87 transactions to 87 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $26.71 per transaction and $26.71 per recipient.

85 transactions worth $1.9K make "Food and Beverage" the top general-payment category in the 2-category breakdown below, 82.8% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Oxford Gene Technology Inc made 2 types of general payments. "Food and Beverage" is the largest category at $1.9K, 82.8% of the company's reported total.

How Oxford Gene Technology Inc divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$1.9K2. Honoraria$400.00
Payment Type Amount Transactions
Food and Beverage $1.9K 85
Honoraria $400.00 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,252.87 (53.9%) of $2,323.62 in this company's General Payments records across 16 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Oxford Gene Technology Inc

The five named recipients with the highest reported General Payments from this company

Memorial Regional Hospital$307.99Moffitt Cancer Center$255.41Hartford Hospital$242.07Eric Vail$236.30Texas Childrens Hospital$211.10
  1. 1

    Memorial Regional Hospital

    $307.99 across 19 reported transactions

  2. 2

    Moffitt Cancer Center

    $255.41 across 12 reported transactions

  3. 3

    Hartford Hospital

    $242.07 across 6 reported transactions

  4. 4

    Eric Vail

    $236.30 across 2 reported transactions

  5. 5

    Texas Childrens Hospital

    $211.10 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $26.71. Average per recipient: $26.71.

Total Amount

$2,323.62

Avg per Transaction

$26.71

Avg per Recipient

$26.71

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Oxford Gene Technology Inc Share

0.0%

#1786 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Oxford Gene Technology Inc

Elekta Medical, S.A.

$2.3K 1 recipients

Ortho Systems

$2.4K 14 recipients

Dymicron

$2.3K 1 recipients

CPM Medical Consultants, LLC

$2.4K 25 recipients

Levita Magnetics International Corp.

$2.4K 60 recipients

Elekta Solutions AB

$2.4K 1 recipients

Frequently Asked Questions

How much did Oxford Gene Technology Inc pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Oxford Gene Technology Inc, totaling $2,323.62 across 87 transactions to physicians and hospitals.
How many physicians received payments from Oxford Gene Technology Inc? ▾
Oxford Gene Technology Inc made payments to 87 physicians and teaching hospitals in 2024. The average payment per recipient was $26.71.
What types of payments did Oxford Gene Technology Inc make? ▾
2 categories of general payment make up Oxford Gene Technology Inc's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Food and Beverage" at $1.9K, representing 82.8% of the company's reported total.
How does Oxford Gene Technology Inc rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Oxford Gene Technology Inc ranks #1786 by total payment amount.
What is the average payment size from Oxford Gene Technology Inc? ▾
In 2024, Oxford Gene Technology Inc averaged $26.71 per transaction across 87 transactions to 87 recipients.
Where does the payment data for Oxford Gene Technology Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Oxford Gene Technology Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.